Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

66.11 -2.46 (-3.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,023,312
Open 68.07
Bid (Size) 66.32 (5)
Ask (Size) 67.28 (1)
Prev. Close 68.57
Today's Range 65.11 - 68.12
52wk Range 57.52 - 139.24
Shares Outstanding 390,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Exposures Product Safety
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities

Performance

YTD
-15.8%
-15.8%
1 Month
-12.2%
-12.2%
3 Month
-23.4%
-23.4%
6 Month
-9.0%
-9.0%
1 Year
-49.7%
-49.7%

More News

Read More
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
From Johnson Fistel, PLLP
Via Business Wire
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tariffs, Trump, and Turmoil
Via The Motley Fool
Topics Economy Government World Trade
Exposures Interest Rates Political Tariff
What Does the Market Think About DexCom?
Via Benzinga
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
What's going on in today's session: S&P500 movers
Via Chartmill
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
Via Benzinga
Exposures Product Safety
2 Growth Stocks to Buy in the Tariff-Fueled Market Correction
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Product Safety Tariff
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
From DexCom, Inc.
Via Business Wire
What 6 Analyst Ratings Have To Say About DexCom
Via Benzinga
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
The Future of Healthcare: 10 Predictions For The Next Decade
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Dexcom Appoints Jon Coleman as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Tuesday's session: top gainers and losers in the S&P500 index
Via Chartmill
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.
Via Chartmill
DexCom (DXCM): 3 Reasons We Love This Stock
Via StockStory
Topics Stocks
Exposures Product Safety US Equities
Is DexCom Gaining or Losing Market Support?
Via Benzinga

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 66.11
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 04/21/25 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 25.83B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 26B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.